Mice Live Longer on Magic Mushrooms
August 22, 2025
Study supports systemic anti-aging potential of psilocybin
2 min read
False
Advertisement
Drug Discovery
How Oligonucleotides Work Their Magic
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
Growing a Whole Brain Organoid
By Stephanie Vine
August 19, 2025
Researchers grow organ integrating cerebral, midbrain and hindbrain that could open up new ways of studying disease and testing drugs.
2 min read
Shaping Drug Discovery with AI
August 15, 2025
A consortium of organizations is looking to set new precedents in compound discovery, validation, and clinical success for patients with delayed cerebral ischemia.
4 min read
Rewiring the Brain: A Dual-Drug Strategy to Tackle Alzheimer’s Disease
August 14, 2025
A tale of two cancer drugs: Study suggests that repurposing letrozole and irinotecan can restore memory and reverse pathology in Alzheimer’s model.
3 min read
Discovery Strategies for Oligonucleotides
By Stephanie Vine
August 14, 2025
Targeting disease at the genetic level isn’t science fiction – it’s oligonucleotides. Hilary Brooks reveals how smarter discovery strategies are reshaping what’s possible in drug development.
10 min read
Kling Bio and Sanofi Team Up to Fast-Track Functional Antibodies
August 11, 2025
Collaboration seeks neutralizing antibodies and respective epitopes against a human viral pathogen.
3 min read
AI Reshaping Drug Discovery
By Michael W. Nestor, Mike Clements
August 6, 2025
Discussing the challenges and AI-based solutions in the earliest stages of drug development
4 min read
Understanding the Role of TRPV1 in Small Molecule Treatments for Obesity and Diabetes
August 4, 2025
Step aside, GLP-1 biologics – there’s a smaller kid in town. Meet the clinical stage Nordic company developing a small molecule TRPV1 antagonist for weight loss and diabetes treatment.
8 min read
From Manual to Metadata: How Novo Nordisk is Rewiring Clinical Trials
July 30, 2025
Tech companies and drug developers are aiming for faster, more efficient, completely compliant clinical trials through the use of AI – and there’s no such thing as too much data.
4 min read
